LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $12.2B | +25.6% | 12.6% | 5.4% |
| Selling, general and administrative (TTM) | $12.2B |
|---|---|
| YoY | +25.6% |
| 5-year CAGR | 12.6% |
| 10-year CAGR | 5.4% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $11.1B | +29.1% |
| 2024 | $8.6B | +16.1% |
| 2023 | $7.4B | +15.0% |
| 2022 | $6.4B | +0.1% |
| 2021 | $6.4B | +5.1% |
| 2020 | $6.1B | −1.5% |
| 2019 | $6.2B | +4.0% |
| 2018 | $6.0B | −0.1% |
| 2017 | $6.0B | −8.4% |
| 2016 | $6.5B | −0.1% |
| 2015 | $6.5B | −1.3% |
| 2014 | $6.6B | −7.1% |
| 2013 | $7.1B | −5.2% |
| 2012 | $7.5B | −4.6% |
| 2011 | $7.9B | +11.7% |
| 2010 | $7.1B | +2.3% |
| 2009 | $6.9B | +4.0% |
| 2008 | $6.6B | +8.7% |
| 2007 | $6.1B | — |